Grow fuller, darker eyebrows

Eyebrow thinning is a common concern and can be caused by several factors, including over-plucking or waxing, aging, hormonal changes, nutritional deficiencies, skin conditions such as eczema or psoriasis, and certain medications or medical treatments. Additionally, genetics may play a role in eyebrow thinning or sparse hair growth.

Latisse is only FDA-approved for the treatment of inadequate eyelash growth, meaning it is considered an off-label prescription for eyebrow growth. This means that Latisse is not FDA-approved for eyebrow growth, but a provider can still prescribe it for that use if they deem it safe and appropriate for a patient. There is research indicating that Latisse may improve eyebrow hair fullness and darkness in people with sparse eyebrows.

Latisse’s effectiveness for eyebrow growth may depend on the underlying cause of the eyebrow loss. For example, if the cause of eyebrow loss is due to a medical condition such as alopecia areata, Latisse may not be effective. Additionally, if the hair follicles on the eyebrow area are damaged or scarred, Latisse may not be able to stimulate hair growth in that area.

Latisse is a medication used to enhance the growth of eyelashes, and while it is not FDA approved for use on eyebrows, it may be prescribed for such use at the provider’s discretion if safe and appropriate for a patient. This is considered to be an “off-label” use. If you are seeking treatment for sparse eyebrows, you can talk to your healthcare provider about whether Latisse may be right for you.

Side effects of Latisse for eyelash growth and which may also occur with use on the eyebrows include:

• Allergic reaction:. Some people may have an allergic reaction to Latisse, which can present with symptoms such as itching, redness, and swelling.

• Skin darkening: Latisse may cause application site hyperpigmentation due to the active ingredient in Latisse, bimatoprost, which can stimulate the production of melanin.

• Unintended hair growth: Latisse may promote hair growth in whichever part of the skin that it comes into regular contact with regularly. Care should be taken to avoid application of Latisse to areas beyond the eyebrows or lash line.

In addition, other side effects of Latisse for eyelash growth include:

• IOP-lowering effect: Concurrent administration of Latisse and intraocular pressure (IOP)-lowering prostaglandin analogs in ocular hypertensive patients may decrease the IOP-lowering effect. Patients using these products concomitantly should be closely monitored for changes to their IOP.

• Allergic reaction: Some people may have an allergic reaction to Latisse, which can present with symptoms such as itching, redness, and swelling.

• Skin darkening: Latisse may cause application site hyperpigmentation due to the active ingredient in Latisse, bimatoprost, which can stimulate the production of melanin.

• Unintended hair growth: Latisse may promote hair growth in whichever part of the skin that it comes into regular contact with regularly. n unintended areas around the eyebrows, such as the cheeks or forehead. Care should be taken to avoid application of Latisse to areas beyond the eyebrows or lash line.

People who should avoid using Latisse on their eyebrows include:

• Those who are pregnant or breastfeeding: The safety of using Latisse during pregnancy or while breastfeeding has not been adequately studied.

• Those with hypersensitivity or allergies to any of the ingredients in Latisse.

• Those who have any rash in the eyebrows or a break in the skin of the eyebrows